Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma
Phase 2
- Conditions
- Melanoma
- Interventions
- Radiation: Stereotactic Ablative Radiosurgery (SART)
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Wolfram Samlowski
- Target Recruit Count
- 50
- Registration Number
- NCT01565837
- Locations
- 🇺🇸
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
Completed
- Conditions
- Melanoma
- Interventions
- Other: Blood Draw
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Wolfram Samlowski
- Target Recruit Count
- 150
- Registration Number
- NCT01528774
- Locations
- 🇺🇸
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
© Copyright 2025. All Rights Reserved by MedPath